Skip to content
Screener

Dyne Therapeutics, Inc. DYN Q4 2025 Annual earnings

Reported March 2, 2026 · Before market open

EPS-$0.76Miss by $0.02
EPS estimate-$0.74

Next report

Nov 4, 2026 (in 3 months)
EPS estimate-$0.86

Financials

Q4 2025

Income statement

See full
Operating income-$116.1M-19.6%
Net income-$112.0M-25.0%
EPS (diluted)-$0.73+17.0%

Balance sheet

See full
Cash & equivalents$893.4M+105%
Total debt$169.2M+605%
Total equity$972.1M+54.3%
Total assets$1.2B+71.7%

Cash flow

See full
Operating cash flow-$111.8M-32.6%
CapEx$484.0K-55.0%
Free cash flow-$112.3M-31.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$3.22B+34.3%
Enterprise value$2.5B+25.7%

Returns & leverage

See full
Return on equity-55.7%-15.0pp
Debt / equity0.2×+0.1×
Current ratio22.3×+6.7×

FAQ

When did Dyne Therapeutics, Inc. report Q4 2025 earnings?
Dyne Therapeutics, Inc. (DYN) reported Q4 2025 earnings on March 2, 2026 before market open.
What were Dyne Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Dyne Therapeutics, Inc. reported eps of $-0.76 for Q4 2025.
Did Dyne Therapeutics, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.74 by $0.02.
How did Dyne Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 13.6% from $-0.88.
Where can I find Dyne Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-084207) and the 10-K periodic report (0001193125-26-084178) directly on SEC EDGAR. The filing index links above go to sec.gov.